More Press Releases

View Older Stories View Newer Stories

Dec 3, 2024 08:00AM Gelband & Company Announces Successful Funding of SPV and Closing of Investment in symGLASS
Dec 3, 2024 08:00AM Compassion International Launches New 'Causes' Platform
Dec 3, 2024 08:02AM Know Rare Launches HealthStoryAI App for People Living with Rare Disease
Dec 3, 2024 08:00AM Celebrating Loyalty: Cargo-Partner Honors Long-Standing Employees Worldwide
Dec 3, 2024 08:01AM GREEN & CLEAN POWER SECURES FINANCING FOR SOLAR AND ENERGY STORAGE PROJECT IN ARKANSAS
Dec 3, 2024 08:01AM Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
Dec 3, 2024 08:01AM Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones
Dec 3, 2024 08:00AM Hyundai Motor Shifts Perceptions by Unveiling All-Electric IONIQ 9 SUV at Iconic Goldstein House in LA
Dec 3, 2024 08:00AM Publication in the Journal, Infection, Demonstrates Clinical Utility of SeptiCyte® RAPID for Early Recognition of Sepsis in Patients After Major Abdominal Surgery
Dec 3, 2024 08:00AM New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
Dec 3, 2024 08:00AM ADVANCION LAUNCHES NEXT-GENERATION MULTIFUNCTIONAL ADDITIVES FOR CONSUMER AND INDUSTRIAL APPLICATIONS
Dec 3, 2024 08:00AM HUB 2025 NORTH AMERICAN OUTLOOK REPORT: 73% OF COMPANIES UNDERINSURED AGAINST PROFIT-THREATENING RISKS
Dec 3, 2024 08:00AM Xsolis Launches New Generative AI Solution to Improve Clinician Efficiency in Mid-Revenue Cycle
Dec 3, 2024 08:00AM Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
Dec 3, 2024 08:00AM Global Luxury Automobile Manufacturer Elevates Dealer Operations with Inovatec’s Propel Dealer Portal
Dec 3, 2024 08:00AM XYO Leads the Rise of DePIN and the Evolving Intersection of Technology and Data Sovereignty in 2024
Dec 3, 2024 08:00AM Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
Dec 3, 2024 08:00AM Modular Medical Announces Conference Call to Provide Business Update
Dec 3, 2024 08:00AM M2i Global, Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
Dec 3, 2024 08:00AM Revolve Announces Completion of Major Interconnection Milestone on 49.6MW Primus Wind Project in the U.S
Dec 3, 2024 08:00AM OSS Announces Follow-On Order and Design Win from a Leading Defense Contractor in Asia for an Autonomous Maritime Application
Dec 3, 2024 08:00AM NOA Lithium Closes $1.1 Million 2nd Tranche of the $2.7 Million Non-Brokered Private Placement
Dec 3, 2024 08:00AM PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
Dec 3, 2024 08:00AM CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
Dec 3, 2024 08:00AM Choreograph Gainesville, Discovery Senior Living's First Resort-Style 55+ Community, Officially Opens Its Doors and Welcomes New Residents
Dec 3, 2024 08:00AM Dr. Alexander Taghva Introduces Focused Ultrasound Treatment for Essential Tremors in Orange County, CA
Dec 3, 2024 08:00AM Simpli.fi Unveils Next Generation AI-Driven Advertising Solutions, Powered by the Company's Highly Granular Unstructured Data Set and Unmatched Campaign Volume
Dec 3, 2024 08:00AM Target RWE Highlights GLP-1 Receptor Agonists in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease at The Liver Meeting 2024
Dec 3, 2024 08:00AM ADP to Present at Upcoming Investor Conference
Dec 3, 2024 08:00AM CoachHub Secures $42M in Growth Financing from HSBC Innovation Banking UK to Fuel AI Innovation and Product Expansion
Dec 3, 2024 08:00AM Clearway Health and Sinai Chicago Announce Strategic Partnership to Transform and Expand Specialty Pharmacy Services for Patients Facing Disparities
Dec 3, 2024 08:00AM Antheia Secures Second Project Agreement with the BioMaP-Consortium Valued at up to $12M
Dec 3, 2024 08:00AM Big Blue Marble Academy Celebrates its Young Learners Raising Nearly $150,000 in Donations in 2024
Dec 3, 2024 08:00AM ManTech Wins $715 Million Marine Corps Warfighting Lab Contract
Dec 3, 2024 08:00AM First Horizon Corporation to post fixed income investor materials on December 3, 2024
Dec 3, 2024 08:00AM May Mobility launches autonomous e-Palette deployment at Toyota Motor Kyushu factory in Fukuoka, Japan
Dec 3, 2024 08:00AM Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024
Dec 3, 2024 08:00AM Stirista Ranked One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500™
Dec 3, 2024 08:00AM Strategic Agreements Put 54 at the Heart of Vietnam's Future Vision for Golf
Dec 3, 2024 08:00AM INTERNATIONAL WOMEN'S FORUM ANNOUNCES NEW BOARD OFFICERS AND DIRECTORS
Dec 3, 2024 08:00AM A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology
Dec 3, 2024 08:00AM Vortex Energy Completes High-Resolution UAV Magnetic Survey at the North Block of the Robinsons River Salt Project
Dec 3, 2024 08:00AM TACO BELL BRINGS THE DRIVE-THRU TO THE BIG GAME, CELEBRATING THE FANS WHO DEFINE WHAT IT MEANS TO LIVE MÁS
Dec 3, 2024 08:00AM #paid Launches First-to-Market Generative AI Principles for the Creator Economy
Dec 3, 2024 08:00AM Enphase Energy Unveils Busbar Power Control to Significantly Reduce Main Electrical Panel Upgrades
Dec 3, 2024 08:00AM Novo Nordisk to present new data highlighting innovative rare blood disorders pipeline at ASH 2024
Dec 3, 2024 08:00AM Entrepreneur Media and Advantage Media Announce Powerful Platform for Top Business Leaders to Grow Influence and Audiences
Dec 3, 2024 08:00AM Saucony® Signs Jackie Gaughan, 2024 U.S. Women's Olympic Marathon Trials Qualifier
Dec 3, 2024 08:00AM ASHFORD HOSPITALITY TRUST ANNOUNCES CLOSING OF NON-TRADED PREFERRED STOCK OFFERING
Dec 3, 2024 08:00AM Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and Oncology
View Newer Stories View Older Stories